Daniel J. Lenihan
Advanced Heart Failure and Transplant Cardiology | Cardiology
1370 Gateway Blvd Ste 200
Murfreesboro,, TN 37129
Murfreesboro,, TN 37129
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 196 publications
Medical strategies of cardiovascular protection to reduce cancer therapy-related cardiovascular toxicity: where do we stand?
Journal: Heart (British Cardiac Society)
Published: December 14, 2025
Immune Checkpoint Inhibitor-Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position Statement.
Journal: JAMA oncology
Published: November 13, 2025
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study.
Journal: Clinical pharmacology and therapeutics
Published: October 14, 2025
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers.
Journal: Cancer medicine
Published: October 12, 2025
Global disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology society.
Journal: Cardio-oncology (London, England)
Published: August 20, 2025
A call to action: improving access to cardiac MRI for diagnosis of immune checkpoint inhibitor related myocarditis in low and middle income countries.
Journal: Cardio-oncology (London, England)
Published: August 09, 2025
Myocardial Strain Measurements Obtained with Fast-Strain-Encoded Cardiac Magnetic Resonance for the Risk Prediction and Early Detection of Chemotherapy-Related Cardiotoxicity Compared to Left Ventricular Ejection Fraction.
Journal: Diagnostics (Basel, Switzerland)
Published: June 27, 2025
Anticoagulation challenges in cancer patients: prevention, detection, and treatment strategies.
Journal: Cardio-oncology (London, England)
Published: April 22, 2025
Considerations for the practical management of cardiovascular risk with Bruton's tyrosine kinase inhibitors for patients with chronic lymphocytic leukemia.
Journal: The oncologist
Published: March 25, 2025
Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosis.
Journal: European heart journal open
Published: February 04, 2025
Last Updated: 09/26/2026